|
|

 |
|
Vol. 3, No. 1, 10 January 2003
|
Other Issues:
|
 |
This Week's Researchers [What is this?]
|
AIDScience Report:
Current HIV/AIDS-related knowledge, attitudes, and practices among the general population in China: Implications for action. Relatively little is known about the AIDS epidemic in China. Results from a recent survey indicate that the general population is very often uninformed about basic issues, and suggest the need for widespread HIV prevention measures.
by Deborah Holtzman et al.
[Free full text article] [About AIDScience articles] [See recent AIDScience articles]
[dEbates: Submit a response to this article]
|
Hot News:
Epicyte advances production of human HIV antibodies in plants. Epicyte Pharmaceutical, Inc., announced that it is growing the first greenhouse plant lines to yield an antibody product for the prevention of HIV. The Plantibodies technology allows Epicyte to produce large quantities of antibodies at substantially reduced capital and manufacturing costs.
[Epicyte's Web site]
|
Enhancement of antibodies to HIV-1 Env by using the molecular adjuvant C3d. Murine and human homologues of the complement component, C3d, were used in a DNA vaccine to enhance the titers of antibody to Env.
Journal of Virology 77(3), February 2003 [Read abstract]
|
Latest News Headlines:
[What is this?]
|
ADODB.Connection error '800a0e7a'
Provider cannot be found. It may not be properly installed.
/Issues/Issue043.asp, line 75 |